Pfizer

Drugmaker AstraZeneca said Monday that late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.

News of another promising COVID-19 vaccine candidate stirred hope on Monday, November 16, 2020, as Canada's case count surpassed the 300,000 mark, with the two hardest-hit provinces continuing to report more than 1,000 daily new infections and a sudden spike in Nunavut triggering a two-week lockdown.

Prime Minister Justin Trudeau said Monday he hopes to see COVID-19 vaccines roll out in Canada early next year, but warned that won’t bring an immediate resolution to the pandemic currently seeing a resurgence in several provinces.

Canada will not cut corners to get a vaccine candidate for COVID-19 approved, the country's chief public health officer said on Tuesday, August 11, 2020.

Canada is negotiating deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to secure millions of doses of their experimental COVID-19 vaccines, in case either is approved for wide-scale use.